A first as GlaxoSmithKline files its malaria vaccine
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has submitted its ground-breaking malaria vaccine RTS,S for approval in the EU, in the hope of using it in Africa, in line with plans announced last year.